Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
Philip N. Hawkins(The Royal Free Hospital), Michael McDermott(University of Leeds), Helen J. Lachmann(Royal Free London NHS Foundation Trust)
Cited by 655
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k